Bromperidol
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
Trade names | Bromidol, Bromodol |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | N05AD06 (WHO) |
Identifiers | |
|
|
CAS Number | 10457-90-6 ![]() |
PubChem (CID) | 2448 |
ChemSpider | 2354 ![]() |
UNII | LYH6F7I22E ![]() |
KEGG | D01101 ![]() |
ChEMBL | CHEMBL28218 ![]() |
ECHA InfoCard | 100.030.845 |
Chemical and physical data | |
Formula | C21H23BrFNO2 |
Molar mass | 420.315 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Bromperidol (marketed as Bromidol, Bromodol) is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966.
References[edit]
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |